2,115 Shares in Mettler-Toledo International, Inc. (NYSE:MTD) Purchased by Oxbow Advisors LLC

Oxbow Advisors LLC acquired a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,115 shares of the medical instruments supplier's stock, valued at approximately $2,498,000.

A number of other institutional investors and hedge funds have also modified their holdings of MTD. Farther Finance Advisors LLC boosted its stake in shares of Mettler-Toledo International by 39.1% in the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after buying an additional 25 shares during the last quarter. QRG Capital Management Inc. lifted its position in Mettler-Toledo International by 29.4% during the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock valued at $577,000 after purchasing an additional 111 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its position in Mettler-Toledo International by 13.3% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock valued at $2,929,000 after purchasing an additional 292 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its position in Mettler-Toledo International by 95.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock valued at $2,600,000 after purchasing an additional 1,073 shares in the last quarter. Finally, Boston Trust Walden Corp lifted its position in Mettler-Toledo International by 7.1% during the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock valued at $40,871,000 after purchasing an additional 2,296 shares in the last quarter. Institutional investors own 95.07% of the company's stock.

Insider Activity

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director directly owned 120 shares of the company's stock, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Trading Up 1.3%

Shares of NYSE:MTD traded up $15.15 on Wednesday, reaching $1,183.71. The company had a trading volume of 202,761 shares, compared to its average volume of 151,180. The firm has a market capitalization of $24.60 billion, a PE ratio of 29.52, a PEG ratio of 3.59 and a beta of 1.37. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,546.93. The firm's 50 day simple moving average is $1,169.38 and its 200-day simple moving average is $1,194.46.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, beating the consensus estimate of $7.90 by $0.29. The business had revenue of $883.74 million for the quarter, compared to the consensus estimate of $876.61 million. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The company's quarterly revenue was down 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $8.89 EPS. As a group, equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on MTD shares. Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 target price on the stock in a research report on Monday, April 7th. Robert W. Baird reduced their price objective on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Wells Fargo & Company boosted their price objective on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price objective for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Jefferies Financial Group upgraded Mettler-Toledo International from an "underperform" rating to a "hold" rating and dropped their target price for the company from $1,200.00 to $1,110.00 in a research report on Monday, May 5th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of "Hold" and an average target price of $1,280.90.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.